The Column GroupFirm match from fund name (lower confidence)
Column Group-Neuro II, LP
Open, writing first checks
Open: first sale Feb 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $100M (Form D)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- Not stated
01 · Thesis
The Column Group is a venture ecosystem funding life sciences innovation, from early technology platforms and single assets to later-stage programs, from inception through exit, with a focus on biotechnology company formation.Inferred from the firm's website
02 · Initial check
$1M to $1.67M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Tim Kutzkey, Managing Partner
- Peter Svennilson, Founder / Managing Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideThe Column Group (TCG) is a venture ecosystem dedicated to fueling scientific innovation in the life sciences industry.
The Column Group (TCG) is a venture ecosystem dedicated to fueling scientific innovation in the life sciences industry.
https://www.thecolumngroup.com/
06 · Sources
Last verified: Oct 28, 2026